CN1147498C - 制备氧氮杂膦-2-胺的方法 - Google Patents

制备氧氮杂膦-2-胺的方法 Download PDF

Info

Publication number
CN1147498C
CN1147498C CNB988087529A CN98808752A CN1147498C CN 1147498 C CN1147498 C CN 1147498C CN B988087529 A CNB988087529 A CN B988087529A CN 98808752 A CN98808752 A CN 98808752A CN 1147498 C CN1147498 C CN 1147498C
Authority
CN
China
Prior art keywords
general formula
compound
chloroethyl
reaction
auxiliary base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB988087529A
Other languages
English (en)
Chinese (zh)
Other versions
CN1268950A (zh
Inventor
U������Ү��
U·尼米耶尔
H·尼格尔
B·库彻尔
I·尼达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Publication of CN1268950A publication Critical patent/CN1268950A/zh
Application granted granted Critical
Publication of CN1147498C publication Critical patent/CN1147498C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CNB988087529A 1997-09-06 1998-08-14 制备氧氮杂膦-2-胺的方法 Expired - Lifetime CN1147498C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19739159.1 1997-09-06
DE19739159A DE19739159C1 (de) 1997-09-06 1997-09-06 Verfahren zur Herstellung von Oxazaphosphorin-2-aminen

Publications (2)

Publication Number Publication Date
CN1268950A CN1268950A (zh) 2000-10-04
CN1147498C true CN1147498C (zh) 2004-04-28

Family

ID=7841505

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988087529A Expired - Lifetime CN1147498C (zh) 1997-09-06 1998-08-14 制备氧氮杂膦-2-胺的方法

Country Status (18)

Country Link
US (1) US6187941B1 (enExample)
EP (1) EP1012152B1 (enExample)
JP (1) JP4278859B2 (enExample)
CN (1) CN1147498C (enExample)
AR (1) AR013467A1 (enExample)
AT (1) ATE225797T1 (enExample)
BR (1) BR9814266B1 (enExample)
CA (1) CA2301104C (enExample)
DE (2) DE19739159C1 (enExample)
DK (1) DK1012152T3 (enExample)
ES (1) ES2185220T3 (enExample)
HU (1) HU226887B1 (enExample)
IL (1) IL134507A (enExample)
IN (1) IN186170B (enExample)
PL (1) PL190097B1 (enExample)
PT (1) PT1012152E (enExample)
WO (1) WO1999012942A1 (enExample)
ZA (1) ZA987741B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2196775C2 (ru) * 2001-03-27 2003-01-20 Государственный научный центр Российской Федерации "НИОПИК" Способ получения 2-[бис-(2-хлорэтил)амино]тетрагидро-2н-1,3,2-оксазафосфорин-2-оксида, моногидрата
CN1607204B (zh) * 2003-10-13 2011-10-26 北京大学 环磷酰胺季铵盐衍生物及其合成和应用
US20110054081A1 (en) * 2009-09-02 2011-03-03 Frank Dierschke Formulation and its use
FR2968662B1 (fr) * 2010-12-10 2013-11-22 Roussy Inst Gustave Nouveaux derives d'oxazaphosphorines pre-activees, utilisation et methode de preparation
US20180086780A1 (en) 2015-04-02 2018-03-29 Przedsiebiorstwo Produkcyjno-Wdrozeniowe Ifotam Sp. Z O.O. Method of production of n,n-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorine-2-amine 2-oxide
CN107936061B (zh) * 2017-12-28 2019-08-06 山东铂源药业有限公司 一种环磷酰胺的合成方法
CN109535201B (zh) * 2019-01-25 2020-04-03 连云港贵科药业有限公司 一种环磷酰胺的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL99688C (enExample) * 1956-12-20
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE1645921C3 (de) * 1966-07-11 1978-10-12 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld 2-Oxo-13,2-osazaphosphorinane, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
GB1235022A (en) * 1969-06-04 1971-06-09 Laeaeke Ag A new method for the production of cyclophosphamide
JPS54157580A (en) * 1978-05-29 1979-12-12 Otsuka Pharmaceut Co Ltd Optically active oxazaphosphorine derivative
JPS54157581A (en) * 1978-05-29 1979-12-12 Otsuka Pharmaceut Co Ltd Oxazaphosphorine derivative
PL119971B1 (en) * 1978-11-06 1982-02-27 Polska Akad Nauk Centrum Process for preparing optically active derivatives of 1,3,2-oxazaphosphorinane,2-oksazofosforinata
JPS5826919B2 (ja) * 1978-11-07 1983-06-06 大塚製薬株式会社 シクロ↓−１，３，２↓−オキサアザホスホル誘導体の製造法
JPS5931787A (ja) * 1982-08-13 1984-02-20 Otsuka Pharmaceut Co Ltd １，３，２−オキサアザホスホリナン−２−オキシド誘導体
PL149593B1 (pl) * 1986-12-18 1990-02-28 Sposób wytwarzania n-acylowych pochodnych 1 , 3 , 2-oksazafosforinanu

Also Published As

Publication number Publication date
IL134507A (en) 2004-06-20
US6187941B1 (en) 2001-02-13
CA2301104A1 (en) 1999-03-18
HK1030422A1 (en) 2001-05-04
HU226887B1 (en) 2010-01-28
DE59805920D1 (de) 2002-11-14
PL190097B1 (pl) 2005-10-31
PT1012152E (pt) 2003-02-28
IL134507A0 (en) 2001-04-30
BR9814266A (pt) 2001-10-09
CN1268950A (zh) 2000-10-04
HUP0003496A2 (hu) 2002-11-28
ATE225797T1 (de) 2002-10-15
PL339188A1 (en) 2000-12-04
DK1012152T3 (da) 2003-02-10
IN186170B (enExample) 2001-06-30
EP1012152A1 (de) 2000-06-28
AR013467A1 (es) 2000-12-27
JP2001515910A (ja) 2001-09-25
EP1012152B1 (de) 2002-10-09
JP4278859B2 (ja) 2009-06-17
WO1999012942A1 (de) 1999-03-18
DE19739159C1 (de) 1999-01-28
ES2185220T3 (es) 2003-04-16
CA2301104C (en) 2009-10-20
ZA987741B (en) 1998-10-08
HUP0003496A3 (en) 2002-12-28
BR9814266B1 (pt) 2009-05-05

Similar Documents

Publication Publication Date Title
JP6190372B2 (ja) 抗ウイルスヌクレオチド類似体を調製する方法
CN101998961B (zh) 经取代的2-苯基-吡啶衍生物
CN1203234A (zh) 三环类吡唑衍生物
CN1252072C (zh) 4,6－二氨基嘧啶并[5,4－d]嘧啶的制备方法
CN1867542A (zh) 在活性胺基存在下制备o－氨基甲酰基化合物的方法
CN1147498C (zh) 制备氧氮杂膦-2-胺的方法
JP6625142B2 (ja) Ｄｐｐ−ｉｖ阻害剤の製造のための新規中間体、その製造方法、及びそれを用いたｄｐｐ−ｉｖ阻害剤の製造方法
CN1890245A (zh) 用于制备微管蛋白抑制剂的方法
CN1914213A (zh) 噻唑并嘧啶的制备方法
CN1053431A (zh) 膦酸酯的非对映选择制备
HK1030422B (en) Method for preparing oxazaphosphorin-2-amines
CN1080265C (zh) 7－烷氧烷基－1,2,4－三唑并[1,5－a]嘧啶衍生物的制备方法
CN1043576C (zh) 吡啶并[1,2,3-de]对二氮萘衍生物,其制备方法及其药物上的应用
US20010047103A1 (en) Process for the preparation of oxazaphosphorine-2-amines
CN1043231C (zh) (E)－α－去氧－α－(氟亚甲基)胞苷的一水合物
CN1093853C (zh) 制备(s)－4－氨基－庚－5,6－二烯酸的新方法及其中间体
CN1314685C (zh) 2,6－二卤代嘌呤的制备方法
JP4094057B2 (ja) Ｎ−置換カルバモイル基を含有する新規のスルファメート化合物とその製造方法
CN1168669A (zh) 制备雷尼替丁的新方法
CN100339383C (zh) 骨靶向药物、合成方法及用途
WO2024186680A1 (en) Methods for preparing pyrrolizidine compounds
CN1930173A (zh) 使用α－碘代－1－氮杂环丁烷乙酸酯和三烷基亚磷酸盐制备头孢菌素中间体的方法
JP3669726B2 (ja) 光学活性３−（ｐ−アルコキシフェニル）グリシッド酸エステル誘導体の製造方法
JP4619505B2 (ja) （２ｓ，４ｒ）−ｎ，ｎ−ジメチル−１−アリルオキシカルボニル−４−置換−２−ピロリジンカルボキサミドの製造方法
CN1283615A (zh) 新方法与中间体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1030422

Country of ref document: HK

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20040428